CHP Respiratory meeting Welcome Dr Ninian Hewitt.

Slides:



Advertisements
Similar presentations
A Seamless Service..  Recognition that COPD and asthma a significant problem for our health economy  Data: 1800 admissions in 1996  1995: COPD and.
Advertisements

Pulmonary Rehabilitation London Clinical Leads:Sam Prigmore & Maria Buxton.
Planning, COPD Hot Topics and CSA preparation Ruth Gooch 11/1/12.
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
Improving Inhaler Technique through Community Pharmacy Service Greater Manchester Area Team Autumn 2014.
Optimising medicines for COPD and Asthma – an integrated approach.
ELJF-CLINICAL v3.04 Quick 6-step tutorial in under 5 minutes.
Respiratory Prescribing
Think Pharmacy Sue Sharpe CEO PSNC. Outline of Talk The Vision for the future community pharmacy The four domains for pharmacy services  Medicines Optimisation.
VALUE AND RESPONSIBLE RESPIRATORY PRESCRIBING Dr Vince Mak, Consultant Physician, NWLH Trust.
Respiratory Service Framework Asthma and COPD Care (Nursing) Project Learning and Development Strategy.
Commissioning the right COPD care for Londoners 7 November 2011 Royal College of Physicians.
Has the Quality and Outcomes Framework resulted in more timely diagnosis of COPD in primary care? LC Hunter, CM Fischbacher, N Hewitt, D McAllister, S.
NHSScotland Event 2015 LEADING INTEGRATION FOR QUALITY B:5 Ready Steady Innovate.
Using CQUINS to improve COPD care on discharge from Acute Trust
South Central Respiratory Project MK Report 10 th October 2011 Nikki Hughes Community Pharmacy Lead NHS Milton keynes.
Respiratory disease programme for Darlington : a catalyst for change. Dr Basil Penney Sr. Claire Adams Darlington CCG Respiratory Leads.
Apprenticeships – Jobs with Training A Great Idea for Young People Presented by Alison Sumpter Association of Learning Providers for Hampshire and the.
Responsible Respiratory Prescribing
P RACTICAL ISSUES IN L ONG T REM M ANAGEMENT OF A STHMA DESPITE REGULAR FOLLOW UP Dr kondekar Santosh TN Medical college Mumbai
Developing Scotland’s health information Dr Brian Robson Clinical Director for eHealth NHS National Services Scotland NMAHP eHealth Leads March 2007.
History Taking Zinc code: UKACL1878ea Date of preparation May 2015 AstraZeneca provided funding & reviewed for technical accuracy.
Wendy Pigg Practice support Pharmacist/Independent Prescriber
Getting the Vision Right: A multi-disciplinary approach to providing integrated care for respiratory patients Dr Irem Patel, Integrated Consultant Respiratory.
Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team Medicines Management Workstream Dr.
Think Pharmacy Sue Sharpe CEO PSNC. Outline of Talk The Vision for the future community pharmacy The four domains for pharmacy services  Medicines Optimisation.
Respiratory audit 318 referrals reviewed. Categories referred.
Building the House of Care for diabetes and respiratory conditions in Berkshire West CCGs TIPS January 28 th 2015 Richard Croft, diabetes and respiratory.
Survey of Respiratory Diagnostic Laboratories to Inform the National COPD Strategy T McCarthy,* A McGowan, ¥ M O’Connor,* on behalf of the National COPD.
NHS improvement update. Data webex - Sources of data Big Picture –Atlas of Variation -
Introduction Method Acknowledgements The impact of respiratory virtual clinics in primary care on responsible respiratory prescribing and inhaled corticosteroid.
Current management of COPD and when to refer?
Medicines Optimisation
In My Practice: Asthma in Portugal
Jessica Case study.
COPD Pathway MDM (10new Or 8new 4 FU)
eLJF-CLINICAL Quick 6-step tutorial in just 3 minutes
A Survey of Knowledge, Attitudes and Practices of Doctors in General Practice in Singapore Towards Chronic Obstructive Pulmonary Disease Dr David Cheong,
COPD PATHWAY AND PRESCRIBING POLICY IN LAMA options (stop SAMA):
Think Pharmacy Sue Sharpe CEO PSNC.
Hampshire and the Isle of Wight Sustainability and Transformation Plan
Barriers to implementing COPD guidelines for non-medical prescribers: a qualitative interview study Alison Paterson1, Anne Kinnear1, Marion Bennie2, Moira.
24/04/2012 NICE guidance and best practice in psychological care for “bipolar disorder” Dr Graeme Reid, Consultant Clinical Psychologist, Step 5, Central.
Monitoring asthma in primary care
Patterns of asthma medications prescriptions among adult patients in the chest and accident and emergency units of a tertiary health care facility in Uganda.
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
Antonio Anzueto, MD, Marc Miravitlles, MD  CHEST 
Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma  Willem M.C. van Aalderen, MD, PhD, Jonathan Grigg,
News from the NHS – Using policy to your advantage
Integrated community Assessment and Support Services (ICASS)
Medicines Optimisation
Schools Emergency Asthma Initiative Wandsworth and Merton
Grampian COPD MCN Delivering Spirometry in a Community Pharmacy setting, a rural solution? Small I (1,2), Clelland J (1,2), Robertson W (1), Freeman D.
COPD in Primary Care Amy Shaheen, MD, MSc.
Dr Mark L Levy’s EMIS Asthma Template
‘Moving in the right direction’
Antimicrobial Stewardship Forum Spring Meeting
The Aerosol Drug Management Improvement Team
Childhood Asthma : Lessons still to be learnt
Varenicline (Champix) Information Pack
Global Initiative for Asthma (GINA) What’s new in GINA 2015?
20 minute update Asthma and COPD
eLJF-CLINICAL Quick 6-step tutorial in just 3 minutes
Launch of new COPD guidelines
How will the NHS Long Term Plan work in our community?
Schematic overview of the suggested pharmacological management of chronic obstructive pulmonary disease (COPD). Schematic overview of the suggested pharmacological.
Benefit–risk balance and its individual determinants with personalised chronic obstructive pulmonary disease (COPD) treatment choices. Benefit–risk balance.
Integration of community pharmacy with PCNs
Asthma Education for Families and HCPs
Choosing inhaler therapy for patients with stable COPD based on the Global Initiative for Chronic Obstructive Lung Disease grouping. Choosing inhaler therapy.
Presentation transcript:

CHP Respiratory meeting Welcome Dr Ninian Hewitt

What we do well Asthma - Control improved with ICS in the 90’s

What we do well COPD - More patients diagnosed - Referrals to PR

What we do well Prescribing - Lothian is one of the most efficient low cost Regions in Scotland

Objectives If we are doing reasonably well why the fuss?

Objectives Correct DIAGNOSIS Correct DRUG CorrectDOSE  All quality based  We can do better for our patients

Quality Improvement Asthma Isle of Wight Involved all Practices and Pharmacies Result Reduced Acute episodes Reduced admissions Reduced prescribing All by concentrating on drug concordance and inhaler technique

Quality Improvement Asthma Northern Ireland  Co-ordinated drug control by GP pharmacy and Patients  Led to lower prescribing and better control This has been sustained!

Quality Improvement Asthma  Step down  Inhaler usage  Acute Prescribing COPD  Diagnosis (spirometry)  Inhaler for appropriate Severity  Maximising exercise tolerance

CORRECT DDD  Prescribing to be introduced by - Katie Johnston & Maureen Reid  LJF first line may cover 90% of all patients  Asthma  COPD

CORRECT DDD Practical sessions – Anne Ritchie/Liz Young Central to all review  Inhaler technique Central to diagnosis esp. COPD  Spirometry

Future  We are at an unprecedented time with new inhalers especially for COPD  Watch out for news from LJF this autumn  New Combined  New dose schedules  LAMA/ LABA

Respiratory Toolkit The paper bag Contents Web addresses Paper inserts Trainhaler COPD 6

Thank You and Enjoy the day